Annual Report

Overview

The report presents Cengild Medical Berhad's FYE 2024 performance, with Group revenue of RM66.85 million. Sustainability achievements include zero serious reportable incidents, one workplace injury, 70% staff training participation and 100% usage of paper and woven bags for take-home medication. The Board includes two women directors, representing 40% of its composition.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: Ends 30 June 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services